Regulation

FDA photo

Inconsistencies between NDI, GRAS raised in letter to FDA

By Hank Schultz

A letter from a member of Congress to FDA calls into question the inconsistencies between the NDI process and how GRAS submissions are evaluated and the lack of communication between the staffs working on these issues.

Getty Images

Guest article

CBD, climate crisis, sustainability: ABC takes a look at 2019 and beyond

By Stefan Gafner and Mark Blumenthal, American Botanical Council

The news about CBD and hemp extracts dominated 2019, says the American Botanical Council. But issues surrounding the ongoing climate crisis, questions of sustainability, and the ongoing questions of adulteration were important topics as well.

Getty Images

Guest article

The legacy of 2019: CBD, mandatory listing and discord

By Steve Mister, President & CEO, Council for Responsible Nutrition

The question of CBDs, and of a mandatory product listing, have dominated a year that for the dietary supplement industry has not been as tumultuous as some.

Follow us

Featured Events

View more

Products

View more

Webinars